Literature DB >> 34229513

Mycoplasma genitalium infection in women reporting dysuria: A pilot study and review of the literature.

Elizabeth Olson1, Kanupriya Gupta1,2, Barbara Van Der Pol1,2, James W Galbraith1,3, William M Geisler1,2.   

Abstract

Mycoplasma genitalium (MG) infection, a sexually transmitted infection (STI), causes cervicitis and may cause reproductive sequelae and adverse pregnancy outcomes. Some MG-infected women report dysuria, a symptom frequently attributed to urinary tract infection (UTI). Given potential MG-associated morbidity and the likelihood that UTI treatment would be ineffective in eradicating MG, an improved understanding of MG infection frequency and clinical significance in young women reporting dysuria is needed. We conducted MG testing on stored urogenital specimens collected in a pilot study on frequency of STIs in young women presenting to an emergency department for dysuria evaluation and performed a literature review on MG infection frequency in women reporting dysuria. Among 25 women presenting for dysuria evaluation in our pilot study, 6 (24.0%) had MG detected and one-third had co-infection with chlamydia and one-third with trichomoniasis; half with MG detected did not receive an antibiotic with known efficacy against MG, while the other half received azithromycin. In five studies identified in the literature review, dysuria was reported by 7%-19% of women and MG detected in 5%-22%. MG infection is common in young women with dysuria and empiric UTI treatment may not be effective against MG. Studies evaluating the clinical significance of MG infection in women reporting dysuria are needed.

Entities:  

Keywords:  Mycoplasma genitalium; dysuria; review; women

Mesh:

Year:  2021        PMID: 34229513      PMCID: PMC8858599          DOI: 10.1177/09564624211030040

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  36 in total

1.  Mycoplasma genitalium: prevalence, clinical significance, and transmission.

Authors:  C Anagrius; B Loré; J S Jensen
Journal:  Sex Transm Infect       Date:  2005-12       Impact factor: 3.519

2.  Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016.

Authors:  M Unemo; K Salado-Rasmussen; M Hansen; A O Olsen; M Falk; D Golparian; M Aasterød; J Ringlander; C Stezckó Nilsson; M Sundqvist; K Schønning; H Moi; H Westh; J S Jensen
Journal:  Clin Microbiol Infect       Date:  2017-09-18       Impact factor: 8.067

3.  The prevalence of urinary tract infections and sexually transmitted disease in women with symptoms of a simple urinary tract infection stratified by low colony count criteria.

Authors:  Tara Shapiro; Mark Dalton; John Hammock; Robert Lavery; John Matjucha; David F Salo
Journal:  Acad Emerg Med       Date:  2005-01       Impact factor: 3.451

4.  Women with symptoms of a urinary tract infection but a negative urine culture: PCR-based quantification of Escherichia coli suggests infection in most cases.

Authors:  S Heytens; A De Sutter; L Coorevits; P Cools; J Boelens; L Van Simaey; T Christiaens; M Vaneechoutte; G Claeys
Journal:  Clin Microbiol Infect       Date:  2017-04-28       Impact factor: 8.067

5.  Mycoplasma genitalium: prevalence and behavioural risk factors in the general population.

Authors:  Berit Andersen; Ineta Sokolowski; Lars Østergaard; Jens Kjølseth Møller; Frede Olesen; Jørgen Skov Jensen
Journal:  Sex Transm Infect       Date:  2006-11-07       Impact factor: 3.519

6.  Mycoplasma genitalium Infection in Young Women Without Urogenital Symptoms Presenting to a Community-Based Emergency Department in Birmingham, Alabama.

Authors:  Stephen D Gragg; Kanupriya A Gupta; Kristin M Olson; Barbara Van Der Pol; Li Xiao; Ken B Waites; William M Geisler
Journal:  Sex Transm Dis       Date:  2021-02-01       Impact factor: 3.868

7.  French Prospective Clinical Evaluation of the Aptima Mycoplasma genitalium CE-IVD Assay and Macrolide Resistance Detection Using Three Distinct Assays.

Authors:  Chloé Le Roy; Sabine Pereyre; Nadège Hénin; Cécile Bébéar
Journal:  J Clin Microbiol       Date:  2017-08-09       Impact factor: 5.948

8.  Comparison between Aptima Assays (Hologic) and the Allplex STI Essential Assay (Seegene) for the diagnosis of Sexually transmitted infections.

Authors:  Adolfo de Salazar; Beatriz Espadafor; Ana Fuentes-López; Antonio Barrientos-Durán; Luis Salvador; Marta Álvarez; Federico García
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

9.  Molecular Testing for Mycoplasma genitalium in the United States: Results from the AMES Prospective Multicenter Clinical Study.

Authors:  Charlotte A Gaydos; Lisa E Manhart; Stephanie N Taylor; Rebecca A Lillis; Edward W Hook; Jeffrey D Klausner; Carmelle V Remillard; Melissa Love; Byron McKinney; Damon K Getman
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

10.  Epidemiology of Mycoplasma genitalium in British men and women aged 16–44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3).

Authors:  Pam Sonnenberg; Catherine A Ison; Soazig Clifton; Nigel Field; Clare Tanton; Kate Soldan; Simon Beddows; Sarah Alexander; Rumena Khanom; Pamela Saunders; Andrew J Copas; Kaye Wellings; Catherine H Mercer; Anne M Johnson
Journal:  Int J Epidemiol       Date:  2015-12       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.